Gary S Herman

US Patent:

50500759, Sep 17, 1991

Filed:

Oct 4, 1988

Appl. No.:

7/253240

Inventors:

Gary E. Herman - South Orange NJ
Kuo-Chu Lee - Franklin Township, Somerset County NJ
Takako Matoba - Morristown NJ

Assignee:

Bell Communications Research, Inc. - Livingston NJ

International Classification:

G06F 722

US Classification:

364200

Abstract:

A single chip high speed VLSI data filter is disclosed. The data filter performs relational and simple numeric operations on a high speed input data stream using a unique instruction set containing no branching instructions.

US Patent:

D2555093, Jun 24, 1980

Filed:

Aug 16, 1978

Appl. No.:

5/934088

Inventors:

Michael Nathan - New York NY
Gary Herman - Philadelphia PA

Assignee:

M. Nathan, Inc. - New York NY

International Classification:

D0301

US Classification:

D 3 59

US Patent:

20210395345, Dec 23, 2021

Filed:

Jun 2, 2021

Appl. No.:

17/337396

Inventors:

- Tarrytown NY, US
Jennifer Hamilton - Ridgefield CT, US
Gary Herman - Princeton NJ, US
Andrea Hooper - Port Chester NY, US
Flonza Isa - Yonkers NY, US
Meagan O'Brien - New York NY, US
Sumathi Sivapalasingam - Brooklyn NY, US
Kenneth Turner - Ridgefield CT, US
Eduardo Forleo Neto - Greenwich CT, US

International Classification:

C07K 16/10
A61P 31/14
A61K 9/00
A61K 31/706
A61K 39/42
C07K 16/28
A61K 45/06

Abstract:

The present invention provides methods for preventing and treating SARS-CoV-2 infections, COVID-19, or symptoms thereof. The methods of the invention feature the administration of one or more antigen-binding molecules (e.g., antibodies) that bind a surface protein of SARS-CoV-2 (e.g., spike protein).

US Patent:

20210253685, Aug 19, 2021

Filed:

Jan 8, 2021

Appl. No.:

17/144385

Inventors:

- Tarrytown NY, US
Eduardo Forleo Neto - Greenwich CT, US
Dinko Gonzalez Trotter - Baldwin Place NY, US
Gary Herman - Princeton NJ, US
Andrew Rankin - Stamford CT, US
Scott Mellis - New Rochelle NY, US

International Classification:

C07K 16/22
A61P 19/02
A61K 39/395

Abstract:

Methods for treating fibrodysplasia ossificans progressiva (FOP) in human subjects are provided. Such methods involve administering to a subject having FOP a therapeutically effective amount of an Activin A antagonist, such as an antibody against Activin A.

US Patent:

20190276527, Sep 12, 2019

Filed:

Mar 1, 2019

Appl. No.:

16/290287

Inventors:

- Tarrytown NY, US
Robert C. Pordy - Ardsley NY, US
Gary Herman - Princeton NJ, US

International Classification:

C07K 16/22
A61K 9/00
A61P 21/00

Abstract:

The present invention relates to compositions and methods for altering body composition in a subject, wherein the alteration of body composition is an increase in muscle mass and a reduction of fat mass simultaneously. The present invention also relates to compositions and methods for reducing fat mass in a subject. The compositions and methods also increase muscle volume and lean body mass in the subject. The present invention also relates to compositions that comprise a GDF8 inhibitor and an Activin A inhibitor and the use of such compositions to treat diseases and disorders characterized by increased fat mass, and/or decreased muscle volume.